Incidence of cardiac anomalies in congenital vertebral deformity: systematic review and meta-analysis of 2910 patients.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Bas, Jose Luis
  • Perez, Silvia
  • Rubio, Pedro
  • Bonilla, Fernando
  • Bovea, Miquel

Grupos

Abstract

PURPOSE: This study aimed to analyze the overall incidence of cardiac abnormalities in patients with congenital scoliosis and the possible influencing factors. METHODS: PubMed, Embase, and Cochrane Library were searched for relevant studies. The quality of the studies was assessed independently by two authors using the methodological index for nonrandomized studies (MINORS) criteria. The following data were extracted from the included studies: bibliometric data, number of patients, number of patients with cardiac anomalies, gender, types of deformity, diagnostic method, type of cardiac anomaly, location, and other associated anomalies. The Review Manager 5.4 software was used to group and analyze all the extracted data. RESULTS: This meta-analysis included nine studies and identified that 487 of 2,910 patients with congenital vertebral deformity had cardiac anomalies diagnosed by ultrasound (21.05%, 95% CI of 16.85-25.25%). The mitral valve prolapse was the most frequent cardiac anomaly (48.45%) followed by an unspecified valvular anomaly (39.81) and an atrial septal defect (29.98). A diagnosis of cardiac anomalies was highest in Europe (28.93%), followed by USA (27.21%) and China (15.33%). Females and formation defects were factors significantly associated with increased incidence of cardiac anomalies: 57.37%, 95% CI of 50.48-64.27% and 40.76%, 95% CI of 28.63-52.89%, respectively. Finally, 27.11% presented associated intramedullary anomalies. CONCLUSIONS: This meta-analysis revealed that the overall incidence of cardiac abnormalities detected in patients with congenital vertebral deformity was 22.56%. The incidence rate of cardiac anomalies was higher in females and those with formation defects. The study offers guidance for ultrasound practitioners to accurately identify and diagnose the most common cardiac anomalies.

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Datos de la publicación

ISSN/ISSNe:
0940-6719, 1432-0932

EUROPEAN SPINE JOURNAL  SPRINGER

Tipo:
Article
Páginas:
2967-2974
Factor de Impacto:
1,231 SCImago
Cuartil:
Q1 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • Cardiac anomalies; Congenital scoliosis; Congenital vertebral deformity; Heart anomalies; Meta-analysis

Proyectos asociados

EFECTIVIDAD BIOMECÁNICA DE LOS TORNILLOS TRANSDISCALES EN LA ESPONDILOLISTESIS L5-S1 FRENTE A TORNILLOS TRANSPEDICULARES Y CAJAS.

Investigador Principal: ISABEL COLLADOS MAESTRE

2014_0666_CRC_COLLADOS . 2014

ESTUDIO DE FASE IIB, ALEATORIZADO, DOBLE CIEGO, CONTROLADO MEDIANTE PLACEBO PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE LA VACUNA DE 4 ANTÍGENOS DE STAPHYLOCOCCUS AUREUS (SA4AG) EN ADULTOS QUE VAN A SOMETERSE A INTERVENCIONES QUIRÚRGICAS PROGRAMADAS DE ARTRODESIS VERTEBRAL POSTERIOR (LUMBAR) INSTRUMENTADA.

Investigador Principal: JUAN BAUTISTA MOLLAR MASERES

B3451002 . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015

BEMIPARINA (HEPARINA DE BAJO PESO MOLECULAR) EN LA PREVENCION DE LA ENFERMEDAD TROMBOEMBOLICA TRAS CIRUGIA DE SUSTITUCION DE TOTAL DE RODILLA. ESTUDIO FASE III ALEATORIO, CONTROLADO, SECUENCIAL, DOBLE CIEGO, PARA COMPARAR LA EFICACIA Y SEGURIDAD DE BEMIPARINA (3.500 U.I. ANTI-XA) CON ENOXAPARINA (40 MG.)

Investigador Principal: PALOMA BAS HERMIDA

ROVI-III/3

ENSAYO CLINICO PARA ESTUDIOS SUCESIVOS DE EFICACIA Y SEGURIDAD DE CELECOXIB: ESTUDIO MULTICENTRICO, DOBLE CIEGO, ALEATORIZADO, DE GRUPOS PARALELOS PARA COMPARAR LA EFICACIA Y TOLERABILIDAD DE CELECOXIB FRENTE A IBUPROFENO EN ESGUINCES DE TOBILLO (SUCCESS-IIE)

Investigador Principal: PALOMA BAS HERMIDA

I49-00-12-155

ESTUDIO DE PRUEBA DE CONCEPTO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DEL ELEZANUMAB EN LA LESIÓN AGUDA TRAUMÁTICA DE MÉDULA ESPINAL CERVICAL.

Investigador Principal: TERESA BAS HERMIDA

M16-077 . 2020

Cirugía de corrección de deformidad vertebral en pacientes con AME tratados con Spinraza.

Investigador Principal: MIGUEL DE PEDRO ABASCAL

SPINAME . 2022

Cita

Compartir